CJC 1295 (without DAC) CND2 2mg*10vials
CJC 1295 is a growth hormone releasing hormone analog designed to stimulate the pituitary gland's natural growth hormone production. This version without DAC (Drug Affinity Complex) has a shorter half-life, producing distinct daily GH pulses, representing a specialized research peptide in endocrine and recovery studies.
The 2mg single-vial specification is the standard concentration, ideal for initial dose-response studies, short-term GH pathway mechanism experiments, and researchers conducting foundational growth hormone research. This low-dose format offers flexibility in experimental design, allowing researchers to explore a wide range of dose levels while minimizing excessive active compound usage.
Through its targeted GHRH receptor pathway, CJC 1295 supports research into natural growth hormone release, muscle growth, fat metabolism, recovery, and sleep quality. The non-DAC version is designed to study the effects of pulsatile GH secretion patterns on physiological processes, offering a distinct research profile compared to long-acting variants.
This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Each batch undergoes rigorous purity testing, with a certificate of analysis provided.
10 vials per pack, suitable for routine laboratory research and foundational endocrine studies.